Targeted Navigation in Hepatocellular Carcinoma (HCC)

Launched by UNIVERSITY OF MIAMI · Feb 7, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the experiences and needs of patients with liver cancer, specifically hepatocellular carcinoma (HCC) and cholangiocarcinoma. The goal is to learn from patients and their families to improve how care is provided during the diagnosis and treatment of liver cancer. By gathering this information, the researchers hope to create a helpful program that guides patients and their loved ones through the challenges they face.

To participate in this trial, you need to be an adult (18 years or older) who has been diagnosed with hepatocellular carcinoma and is enrolled in a specific liver disease registry. Caregivers, advocates, and healthcare providers involved in HCC care can also take part. Participants will share their thoughts and experiences in interviews, helping the researchers identify important needs that may not have been addressed yet. This study is currently recruiting participants, and it's a chance to contribute to better care for future liver cancer patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * HCC Patients:
• • Enrolled or eligible for enrollment in Unified Prospective Registry and Biorepository of Patients with Chronic Liver Disease or Hepatobiliary Cancers Including Hepatocellular Carcinoma (HCC) and Cholangiocarcinoma.
• • Diagnosis of hepatocellular carcinoma, confirmed by clinical chart review and International Classification of Diseases, Tenth Revision (ICD-10) C22.0.
• • Adults, age 18 or older
• • Able to provide informed consent
• * All other interviewees:
• • Advocates who will self-identify as having had HCC.
• • Others who self-identify as either a caregiver or support person of an HCC patient.
• • Physicians/Licensed Independent Practitioners, Social Workers, Nurse Navigators, and Research Coordinators will all self-identify as being involved in the care of HCC patients.
• Exclusion Criteria:
• • Unable to speak Spanish or English
• • West Haven Grade 2 or higher hepatic encephalopathy19 or other cognitive impairment.
• • Adults unable or unwilling to consent
• • Individuals who are not yet adults (infants, children, teenagers)
• • Prisoners
• • Given that this study is minimal risk and there are no risks to a potential fetus, investigators will not exclude pregnant women; however, no data about pregnancy or their fetus is being collected